Older adults, patients with weakened immune systems, individuals living in long-term facilities, and those with underlying cardiopulmonary disease are at a higher risk of developing severe RSV infection outcomes.
Ahead of the fall and winter RSV season, AREXVY is now widely available in major retail pharmacies and anticipated to be covered by most Medicare and commercial insurance plans
.
A recent report published in Morbidity and Mortality Weekly Report provided clinical guidance on Respiratory syncytial virus (RSV) vaccines for adults ≥60 years.
Reporting on COVID-19 vaccine in children: academic research resrouces journalistsresource.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journalistsresource.org Daily Mail and Mail on Sunday newspapers.